Central variant of posterior reversible encephalopathy syndrome in systemic lupus erythematosus: new associations?

Lupus. 2010 Feb;19(2):225-6. doi: 10.1177/0961203309345749. Epub 2009 Oct 30.

Authors

A K Bag, J K Curé, J C Sullivan, G H Roberson

PMID: 19880556
DOI: 10.1177/0961203309345749

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antirheumatic Agents / adverse effects
Antirheumatic Agents / therapeutic use
Female
Humans
Hydroxychloroquine / adverse effects
Hydroxychloroquine / therapeutic use
Immunosuppressive Agents / adverse effects
Immunosuppressive Agents / therapeutic use
Lupus Erythematosus, Systemic / complications*
Lupus Erythematosus, Systemic / drug therapy
Mercaptopurine / adverse effects
Mercaptopurine / therapeutic use
Posterior Leukoencephalopathy Syndrome / etiology*
Posterior Leukoencephalopathy Syndrome / physiopathology
Young Adult

Substances

Antirheumatic Agents
Immunosuppressive Agents
Hydroxychloroquine
Mercaptopurine